« Home | Wrangling Impedes Transfer Of Civilian Anthrax Vac... » | FDA Plans Use of Unapproved Drugs in WMD Events » | ‘That shot messed him up’ » | Pneumonia again hits troops in Middle East » | Experts Say Civilian Smallpox Shots Not Needed » | Soldier seeks answers in medical separation » | Air Force veteran claims smallpox vaccine made him... » | Acambis upbeat on smallpox contract » | MoD gags Gulf war research » | Proposed U.S. Biological Research Could Challenge ... »

National Preparedness Strategy to be Debated at RNC Security Roundtable in NY

WASHINGTON, Aug. 20 /PRNewswire/ -- Increased uniformed security, more checkpoints and additional barricades were all tangible signs that American cities were heeding the warnings earlier this month of a heightened terrorism alert, Code Orange, sounded by the federal Department of Homeland Security.

Despite the relevant information and subsequent terror threat warning, civilians and local government officials still concede the federal government should be doing more to better equip our nation's cities and their police, fire and emergency first responders.

Key members of the House Select Committee on Homeland Security will join a diverse group of governors, mayors, police, emergency services officials and terrorism experts to discuss this and other new homeland security challenges Tuesday, August 30th, at 10 a.m. at the Hilton New York, 1335 Avenue of the Americas, during the Republican National Convention in New York City.

The discussion will focus generally on American preparedness and the role of Federalism in supporting homeland security funding for cities and states to protect against another terrorism attack, particularly bio-terror. The forum is being hosted by Lansing, Michigan-based BioPort Corporation, makers of the only FDA-approved and licensed anthrax vaccine, BioThrax, which has been used to immunize more than 1.1 million U.S. military service members during the past six years.

As the presidential elections approach, security analysts are predicting the likelihood of another terror attack on U.S. soil, particularly bio-terror, is high. As part of his administration efforts to address this President George W. Bush recently signed into law, Project Bioshield, a $5.6 billion, 10-year initiative which gives the government the authority to create and stockpile drugs to fight bio-terrorism.

"There is a significant world-wide demand for anthrax vaccine for the protection of both military and civilian populations, including first responders," Bob Kramer, the company's president, said. "We're looking forward to this opportunity to hear from a significant number of people who have shared interests," he said.